ENTITY

I'Rom Group (2372 JP)

23
Analysis
Health CareJapan
I'rom Group Co., Ltd. provides management services on clinical trials and staffing consulting services including providing nurses, pharmacists, and clinical pathologists to medical institutions as well as training medicalrelated staffs. The Company also provides and leases facilities and finances for these who are to start their clinics.
more
Refresh
bullishI'Rom Group
14 May 2024 00:39

I'rom Group (2372 JP): Blackstone-Sponsored Pre-Conditional MBO at JPY2,800

The offer is attractive and requires a 37% minority acceptance rate. While the timing of regulatory approvals is a risk, the transaction is a done...

Logo
292 Views
Share
bullishI'Rom Group
13 May 2024 18:08

Blackstone to Take I'rom (2372 JP) Private in MBO at ¥2800/Share (49% Premium)

Blackstone is sponsoring the other part of an MBO where CEO Mori-san who controls 47% is taking out the reasonably fast-growing SMO/CRO business at...

Logo
307 Views
Share
bullishFancl Corp
01 Jul 2024 07:00

(Mostly) Asia M&A, June 2024: Fancl, Capitol Health, Infocom,Jeisys Medical, Nagatanien, Henlius Bio

For the month of June, 8 new deals were discussed on Smartkarma with an overall deal size of ~US$6bn. The average premium for the new deals...

Logo
330 Views
Share
01 Jul 2024 00:27

Merger Arb Mondays (01 Jul) - Henlius, China TCM, GA Pack, CPMC, Asia Cement, Great Eastern

This week, the highest gross spreads are HEC Pharma (121.3%), China TCM (26.7%), Hollysys (22.5%), Ansarada (13.1%), Asia Cement China (12.6%), A8...

Logo
369 Views
Share
bullishJeisys Medical
15 Jun 2024 15:00

(Mostly) Asia-Pac M&A: Fancl, Jeisys Medical, A8 New Media, Bapcor, Helios Techno,Tatsuta Electric

This insight provides a summary of gross/annualised spreads (on deals discussed on Smartkarma) across Asia-Pacific as at the last trading date, and...

Logo
190 Views
Share
x